Abstract
This chapter reviews the utility of measuring biometric parameters as they relate to the practice of lifestyle medicine and estimating risk for type-2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD). The new 2013 American College of Cardiology-American Heart Association (ACC-AHA) Prevention Guidelines provide guidance as to which additional factors aid in improved net reclassification. These are explored in detail. The 2013 ACC-AHA Guidelines recommended lifestyle change as the foundation for primary prevention and also as crucially important to deal with residual risk in secondary prevention. The assessment of the metabolic syndrome (MetS)continues to be of clinical value to clinicians as it identifies metabolic parameters that are easily measurable, understood by the patient as markers of a poor cardio-metabolic prognosis, and importantly, markers that all improve with lifestyle changes.
| Original language | English (US) |
|---|---|
| Title of host publication | Lifestyle Medicine |
| Subtitle of host publication | A Manual for Clinical Practice |
| Publisher | Springer International Publishing |
| Pages | 83-88 |
| Number of pages | 6 |
| ISBN (Electronic) | 9783319246871 |
| ISBN (Print) | 9783319246857 |
| DOIs | |
| State | Published - Mar 18 2016 |
Keywords
- Atherosclerotic cardiovascular risk
- Biomarkers
- Coronary artery calcium score
- Metabolic syndrome
- Residual risk
ASJC Scopus subject areas
- General Medicine
